MUMBAI : Ajay Piramal-led Piramal Enterprises Ltd (PEL) reported a 15.3% increase in its net profit to ₹554 crore for the September ended quarter on the back of a robust performance in its pharma and healthcare business. The Mumbai-based diversified conglomerate, which has businesses across financial services, pharma, real estate, among others, saw its revenue jump 18% to ₹3603.56 crore during the reporting quarter. Besides, revenue of healthcare insights and analytics grew 14% to ₹333 crore. "Pharma and healthcare insights businesses continue to consistently deliver strong performance quarter on quarter, acting as a natural hedge and bringing stability to the company’s performance, even in the most volatile market environment," he said. During the reporting quarter, PEL’s financial services grew 13% to ₹1,954 crore.

Source: Mint October 21, 2019 10:07 UTC